164 related articles for article (PubMed ID: 35565877)
21. Comparison of medical resource consumption between oral cavity squamous cell carcinoma with and without sarcopenia: A nationwide population-based cohort study.
Chen WM; Chang CH; Ko JY; Chen MC; Shia BC; Wu SY
Head Neck; 2023 Jul; 45(7):1717-1727. PubMed ID: 37141406
[TBL] [Abstract][Full Text] [Related]
22. Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
Hou GM; Jiang C; Du JP; Yuan KF
Cancer Med; 2022 Jan; 11(2):317-331. PubMed ID: 34866356
[TBL] [Abstract][Full Text] [Related]
23. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
24. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer.
Nishigori T; Okabe H; Tanaka E; Tsunoda S; Hisamori S; Sakai Y
J Surg Oncol; 2016 May; 113(6):678-84. PubMed ID: 26936808
[TBL] [Abstract][Full Text] [Related]
25. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
[TBL] [Abstract][Full Text] [Related]
26. Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma.
Yang J; Chen K; Zheng C; Chen K; Lin J; Meng Q; Chen Z; Deng L; Yu H; Deng T; Bo Z; He Q; Wang Y; Chen G
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2383-2392. PubMed ID: 35854105
[TBL] [Abstract][Full Text] [Related]
27. Impact of preoperative sarcopenia on postoperative complications and prognosis of gastric cancer resection: A meta-analysis of cohort studies.
Chen F; Chi J; Liu Y; Fan L; Hu K
Arch Gerontol Geriatr; 2022; 98():104534. PubMed ID: 34601314
[TBL] [Abstract][Full Text] [Related]
28. Impact of Sarcopenia as a Prognostic Factor on Reductive Hepatectomy for Advanced Hepatocellular Carcinoma.
Omiya S; Komatsu S; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Sofue K; Yano Y; Sakai Y; Yanagimoto H; Toyama H; Ajiki T; Fukumoto T
Anticancer Res; 2021 Nov; 41(11):5775-5783. PubMed ID: 34732451
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of pancreatic dose-volume metrics on sarcopenia rate in gastric cancer patients treated with adjuvant chemoradiotherapy.
Li Y; Wang WB; Jiang HG; Dai J; Xia L; Chen J; Xie CH; Peng J; Liao ZK; Gao Y; Zhou YF; Zhou FX
Clin Nutr; 2019 Aug; 38(4):1713-1720. PubMed ID: 30122263
[TBL] [Abstract][Full Text] [Related]
30. Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder.
Chen VC; Lee MJ; Yang YH; Lu ML; Chiu WC; Dewey ME
Drug Alcohol Depend; 2021 Feb; 219():108495. PubMed ID: 33429293
[TBL] [Abstract][Full Text] [Related]
31. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Yin C; Narumi A; Omura Y; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Kobayashi M; Araki T; McMillan DC; Miki C; Kusunoki M
JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1322-1333. PubMed ID: 29761898
[TBL] [Abstract][Full Text] [Related]
32. Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma.
Yang JF; Huang WY; Lo CH; Lee MS; Lin CS; Shen PC; Dai YH; Wang YF; Chen TW
Sci Rep; 2022 Nov; 12(1):19100. PubMed ID: 36352042
[TBL] [Abstract][Full Text] [Related]
33. Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.
Nakashima Y; Saeki H; Nakanishi R; Sugiyama M; Kurashige J; Oki E; Maehara Y
Ann Surg; 2018 Jun; 267(6):1100-1104. PubMed ID: 28437312
[TBL] [Abstract][Full Text] [Related]
34. Sarcopenia and Comorbidity in Gastric Cancer Surgery as a Useful Combined Factor to Predict Eventual Death from Other Causes.
Kuwada K; Kuroda S; Kikuchi S; Yoshida R; Nishizaki M; Kagawa S; Fujiwara T
Ann Surg Oncol; 2018 May; 25(5):1160-1166. PubMed ID: 29404820
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
[TBL] [Abstract][Full Text] [Related]
36. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
[TBL] [Abstract][Full Text] [Related]
37. Dementia risk after major elective surgery based on the route of anaesthesia: A propensity score-matched population-based cohort study.
Sun M; Chen WM; Wu SY; Zhang J
EClinicalMedicine; 2023 Jan; 55():101727. PubMed ID: 36386032
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib: A retrospective analysis.
Dong D; Shi JY; Shang X; Liu B; Xu WL; Cui GZ; Wang NY
Medicine (Baltimore); 2022 Feb; 101(5):e28680. PubMed ID: 35119010
[TBL] [Abstract][Full Text] [Related]
39. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
40. Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database.
Kim DS; Kim HJ; Ahn HS
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2855-2865. PubMed ID: 35660949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
